none
Conditions
Interventions
Propofol group:Propofol
Remimazolam group:Remimazolam
Sponsors
The Second Xiangya Hospital, Central South University
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. Age 18–64 years; 2. ASA classification I–II; 3. BMI 18–28 kg/m^2; 4. Patients scheduled for elective surgery under general anesthesia; 5. Voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Allergy to benzodiazepines; 2. Difficult airway assessed by an anesthesiologist; 3. Previous diagnosis of coronary heart disease or other cardiovascular and pulmonary dysfunction; 4. Diagnosed with mental disorders such as depression, anxiety, schizophrenia, or abuse of medications or alcohol; 5. Significant abnormalities in liver and kidney function laboratory test results; 6. Structural abnormalities of the heart or lungs found in imaging examinations; 7. Patients who refuse to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alpha-band spectral power; | — |
Secondary
| Measure | Time frame |
|---|---|
| Delta-band spectral power;PSI values at different time points;Alpha-band coherence;Collected using the SedLine EEG monitoring system; | — |
Countries
China
Contacts
Public ContactHaiding Zou
The Second Xiangya Hospital, Central South University
Outcome results
None listed